An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica In 2006, a biotech company halted development of the peptide CJC 1295 after a healthy subject died of a heart attack during a phase two trial. Whether the compound caused the death was Record 769 arrests and USD 65 million in illicit pharmaceuticals seized in global bust Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of All Sterile Compounded Drugs Due to a Potential Lack of Sterility Assurance FDA CJC 1295 Ipamorelin Dosage Protocol: The Complete Clinical Guide to Dosing, Cycling, and Injection Perfect B Why Are People Injecting Themselves with Peptides? The New Yorker